Assignee profile:

Sequella, Inc.

City:

Rockville, Maryland

Country:

United States

Published Applications:

9

Last publication date:

2011-09-01

Patent Grants:

9

Last grant date:

2013-08-06

Top Inventors for applications by Sequella, Inc.

These are the the leading inventors for applications assigned to Sequella, Inc.:

Recent patent applications by Sequella, Inc.

Sequella, Inc. based in Rockville, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2011-09-01 ✅ Patent 8,501,400 granted on 2013-08-06
US20110212457A1
Chemistry; metallurgy

Methods and compositions for determining the pathogenic status of infectious agents

#2 | 2011-05-19 ✅ Patent 8,268,894 granted on 2012-09-18
US20110118307A1
Chemistry; metallurgy

Compositions and methods for the treatment of infectious diseases

#3 | 2010-10-28 ✅ Patent 8,198,303 granted on 2012-06-12
US20100273826A1
Human necessities

Methods of use and compositions for the diagnosis and treatment of infectious diseases

#4 | 2010-01-26 ✅ Patent 7,652,039 granted on 2010-01-26
US10441272
-

Methods of use and compositions for the diagnosis and treatment of infectious disease

#5 | 2009-07-30 ✅ Patent 8,202,910 granted on 2012-06-19
US20090192173A1
Human necessities

Compositions and methods for treatment of infectious disease

#6 | 2009-02-19 ✅ Patent 7,919,234 granted on 2011-04-05
US20090047658A1
Chemistry; metallurgy

Methods and compositions for determining the pathogenic status of infectious agents

#7 | 2006-07-06 ✅ Patent 7,456,222 granted on 2008-11-25
US20060148904A1
Human necessities

Anti tubercular drug: compositions and methods

#8 | 2006-01-26 ✅ Patent 7,842,729 granted on 2010-11-30
US20060020041A1
Chemistry; metallurgy

Anti tubercular drug: compositions and methods

#9 | 2005-05-26 ✅ Patent 7,884,097 granted on 2011-02-08
US20050113574A1
Human necessities

Methods and compositions comprising diamines as new anti-tubercular therapeutics

AssigneeID:

410895 ⎘